These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 2487947)

  • 1. [Current views on the therapeutic use of heparin and antithrombin III in disseminated intravascular coagulation].
    Sobczyk J; Swietliński J; Podleśny-Owsińska T
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):896-8. PubMed ID: 2487947
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapeutic modalities to ameliorate endotoxin induced DIC in the rats.
    Bahrami S; Paul E; Redl H; Schlag G
    Prog Clin Biol Res; 1989; 308():977-82. PubMed ID: 2780743
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-coagulant therapy--antithrombin III].
    Tsuji H
    Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
    Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
    Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithrombin deficiency in special clinical syndromes--Part II: panel discussion #2.
    Sacher R
    Semin Hematol; 1995 Oct; 32(4 Suppl 2):67-71. PubMed ID: 8821213
    [No Abstract]   [Full Text] [Related]  

  • 7. [Studies on antithrombin III. II. The role for antithrombin III (ATIII) in the control of disseminated intravascular coagulation (DIC). (The effect of the administration of ATIII concentrates in experimental DIC and in clinical DIC) (author's transl)].
    Takahashi K
    Nihon Ketsueki Gakkai Zasshi; 1980 Oct; 43(5):889-97. PubMed ID: 6940410
    [No Abstract]   [Full Text] [Related]  

  • 8. Anticoagulant therapy by continuous heparin-antithrombin III infusion in newborns with disseminated intravascular coagulation.
    von Kries R; Stannigel H; Göbel U
    Eur J Pediatr; 1985 Jul; 144(2):191-4. PubMed ID: 4043133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
    Hanada T; Abe T; Takita H
    Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiology, clinical significance and therapy of antithrombin III deficiencies].
    Lechner K; Thaler E; Niessner H
    Acta Med Austriaca; 1983; 10(5):129-35. PubMed ID: 6666509
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heparin, low molecular weight heparin, heparinoid, and antithrombin III therapy of disseminated intravascular coagulation].
    Nakagawa M
    Nihon Rinsho; 1993 Jan; 51(1):87-92. PubMed ID: 7679453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [An experimental study on the protective effect of ATIII against acute disseminated intravascular coagulation].
    Takei H
    Nihon Ketsueki Gakkai Zasshi; 1986 Aug; 49(5):1081-90. PubMed ID: 3788435
    [No Abstract]   [Full Text] [Related]  

  • 14. Antithrombin III patterns in disseminated intravascular coagulation.
    Bick RL; Bick MD; Fekete LF
    Am J Clin Pathol; 1980 Apr; 73(4):577-83. PubMed ID: 7369182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endotoxin-induced intravascular coagulation (DIC) and its therapy.
    Prager RL; Dunn EL; Kirsh MM; Penner JA
    Adv Shock Res; 1979; 2():277-87. PubMed ID: 400581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assay for activity of heparin-antithrombin III complex during treatment of DIC with heparin and its clinical significance].
    Tomihara T; Shimazu C; Yasuda K; Kazama M; Abe T
    Rinsho Byori; 1986 Feb; 34(2):179-84. PubMed ID: 3702087
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapeutic use of antithrombin III in shock and disseminated intravascular coagulation.
    Vinazzer H
    Semin Thromb Hemost; 1989 Jul; 15(3):347-52. PubMed ID: 2688106
    [No Abstract]   [Full Text] [Related]  

  • 18. Differences between functional and immunologic determinations of plasma antithrombin during the treatment of disseminated intravascular coagulation by infusion of antithrombin III concentrate.
    Jespersen J; Rasmussen NR; Sidelmann J
    Acta Chir Scand Suppl; 1982; 509():105-7. PubMed ID: 6962611
    [No Abstract]   [Full Text] [Related]  

  • 19. Current management of disseminated intravascular coagulation.
    Wheeler A; Rubenstein EB
    Oncology (Williston Park); 1994 Sep; 8(9):69-73; discussion 73-6, 79. PubMed ID: 7993725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Therapy of disseminated intravascular coagulation].
    Matsuda T
    Rinsho Byori; 1985 Jun; Spec No 63():79-89. PubMed ID: 3930817
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.